Protection by selenium against gentamicin-induced acute renal damage in the rat.
Gentamicin has been shown to induce renal tubular damage in man and laboratory animals and to result in elevated urinary excretion of some enzymes associated with specific cell regions in the kidney. In the present investigation, the possible protective effect of selenium against gentamicin-induced renal damage was tested by measuring the urinary excretion of some enzymes in the presence and absence of selenium. Our results show that a prior subcutaneous injection of selenium to rats for two days followed by a simultaneous S.C. injection of gentamicin and selenium resulted in a marked reduction in the excretion of such biochemical systems as the urine volume, urinary proteins, alkaline and acid phosphatases, beta-glucuronidase, muramidase, and glutamate dehydrogenase. Renal functional studies revealed that selenium-treated rats suffered less adverse effects compared to rats treated with gentamicin alone. Urinary acid phosphatase, beta-glucuronidase and muramidase, the three lysosomal enzymes tested, appeared to respond most readily to protection by selenium.
D000135:Acid Phosphatase / Q000652:urine; D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D000469:Alkaline Phosphatase / Q000652:urine; D000818:Animals; D005839:Gentamicins / Q000037:antagonists & inhibitors* / Q000633:toxicity; D005966:Glucuronidase / Q000652:urine; D005969:Glutamate Dehydrogenase / Q000652:urine; D007668:Kidney / Q000201:enzymology; D007677:Kidney Function Tests; D008297:Male; D009113:Muramidase / Q000652:urine; D051381:Rats; D012643:Selenium / Q000494:pharmacology*
D005839:Gentamicins; D005969:Glutamate Dehydrogenase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D009113:Muramidase; D005966:Glucuronidase; D012643:Selenium